CRDL
Cardiol Therapeutics Inc. Class A Common SharesRecent alerts on CRDL
All signals →
SEC filing
CRDL Announces Annual General Meeting on June 24, 2026, to Elect Directors and Appoint Auditors
7d ago
SEC filing
CRDL Reports $1.2B Revenue, $0.15 EPS, +120% YoY, Launches $500M Buyback, MAVERIC Trial 75% Enrolled
26d ago
Scanner
Unusual buy pressure (4.3x avg, 99% up-volume, +5.3% / +0.06 intraday, above VWAP)
83d ago
News
Cardiol Therapeutics announces $13.5M bought-deal private placement
137d ago
News
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies
151d ago
Get push alerts for CRDL
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS